In the last 12 months, insiders at Vivos Therapeutics, Inc. ($VVOS) filed 19 transactions with the SEC: 10 open-market purchases totaling $1,834,242 and 0 sales totaling $0. Net insider sentiment: net buying.
Vivos Therapeutics, Inc. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Skaff Michael C (Not found) — 5 transactions totaling $1,813,862
- Huntsman Ronald Kirk (Chief Executive Officer) — 7 transactions totaling $20,386
- Amman Bradford K. (Chief Financial Officer) — 2 transactions totaling $5
- Green Ralph Elias (Director) — 1 transaction totaling $2
- Krammer Anja B (Director) — 1 transaction totaling $2
View all SEC Filings for Vivos Therapeutics, Inc. (VVOS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Skaff Michael C | Not found | P | Common Stock | 308848 | $1.34 | 1,353,625.0000 | 8,266,877 | 29.56% | 3.74% |
| March 31, 2026 | Skaff Michael C | Not found | P | Common Stock | 1044777 | $1.34 | 1,044,777.0000 | 8,266,877 | 9999.99% | 12.64% |
| March 31, 2026 | Skaff Michael C | Not found | P | Series B Common Stock Warrant | 1783582 | $1.34 | 1,783,582.0000 | 8,266,877 | 9999.99% | 21.58% |
| March 31, 2026 | Skaff Michael C | Not found | P | Series A Common Stock Warrant | 1783582 | $1.34 | 1,783,582.0000 | 8,266,877 | 9999.99% | 21.58% |
| March 31, 2026 | Skaff Michael C | Not found | P | Pre-Funded Warrant | 429957 | $1.34 | 429,957.0000 | 8,266,877 | 9999.99% | 5.20% |
| Nov. 26, 2024 | Huntsman Ronald Kirk | Chief Executive Officer | A | Stock Option (Right to Buy) | 315421 | $2.64 | 364,755.0000 | 1,833,877 | 639.36% | 17.20% |
| Nov. 26, 2024 | Amman Bradford K. | Chief Financial Officer | A | Stock Option (Right to Buy) | 149533 | $2.64 | 180,533.0000 | 1,833,877 | 482.36% | 8.15% |
| June 20, 2024 | Lindsay Mark F. | Director | A | Stock Option (Right to Buy) | 4000 | $2.38 | 7,067.0000 | 1,833,877 | 130.42% | 0.22% |
| June 20, 2024 | Amman Bradford K. | Chief Financial Officer | A | Stock Option (Right to Buy) | 15000 | $2.38 | 31,667.0000 | 1,833,877 | 90.00% | 0.82% |
| June 20, 2024 | Green Ralph Elias | Director | A | Stock Option (Right to Buy) | 4000 | $2.38 | 7,067.0000 | 1,833,877 | 130.42% | 0.22% |
| June 20, 2024 | Krammer Anja B | Director | A | Stock Option (Right to Buy) | 4000 | $2.38 | 7,067.0000 | 1,833,877 | 130.42% | 0.22% |
| June 20, 2024 | Thompson Matthew | Director | A | Stock Option (Right to Buy) | 4000 | $2.38 | 7,067.0000 | 1,833,877 | 130.42% | 0.22% |
| June 20, 2024 | SOKOLOW LEONARD J | Director | A | Stock Option (Right to Buy) | 4000 | $2.38 | 7,467.0000 | 1,833,877 | 115.37% | 0.22% |
| June 20, 2024 | Huntsman Ronald Kirk | Chief Executive Officer | A | Stock Option (Right to Buy) | 20000 | $2.38 | 49,334.0000 | 1,833,877 | 68.18% | 1.09% |
| June 20, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 14000 | $0.53 | 1,826,521.0000 | 0 | 0.77% | 0.00% |
| June 15, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 21 | $0.50 | 1,797,521.0000 | 0 | 0.00% | 0.00% |
| June 16, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 10000 | $0.54 | 1,807,521.0000 | 0 | 0.56% | 0.00% |
| June 16, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 5000 | $0.53 | 1,812,521.0000 | 0 | 0.28% | 0.00% |
| June 14, 2023 | Huntsman Ronald Kirk | Chief Executive Officer | P | Common Stock | 10000 | $0.49 | 1,797,500.0000 | 0 | 0.56% | 0.00% |